CONFERENCE SERIES: Technology & Tools for Life Sciences
Recorded at: Leaders in Biobanking Congress
ORDER NOW
.jpg "Collaboration and Biospecimen Sharing between Multiple Biorepositories")
About this Product:
Few biorepositories contain sufficient numbers of samples to perform large research studies, necessitating collaboration between multiple sites. The mass availability of high-quality biological specimens for research requires the development of standardized methods for collection, long-term storage, retrieval and distribution. The use of standard operating procedures (SOPs) is fundamental and widespread. However, standardized data collection, rigorous data management, and uniform informed consent procedures are becoming increasingly valuable for collaboration between researchers in this network. This workshop is designed to discuss a new standard for successful collaboration, providing scientists and clinicians with methods to simplify specimen sharing, with complete phenotypic and clinical information associated with samples.
About this Product:
3 Presentations
86 Slides
Over 96 Minutes
Individual: $345
Site License: $1380
Formats Available:
Digital Download
On Demand
DVD
Agenda At A Glance:
The NCI Cancer Human Biobank (caHUB): A National Center for Biospecimen Science and Standards Development
Latarsha Carithers, Ph.D., Project Manager, Office of Biorepositories and Biospecimen Research, National Cancer Institute
Biography: Latarsha Carithers is a Project Manager at the Biorepositories and Biospecimen Research Branch (BBRB) within the Cancer Diagnosis Program at the National Cancer Institute. In this role, she provides oversight and scientific direction for the Biospecimen Pre-analytical Variables (BPV) Program. The BPV Program is designed to systematically investigate the effects of individual pre-analytical variables on the quality of biospecimens. The results of this study will be used to develop evidence-based protocols for optimal collection, processing, and storage of biospecimens. Prior to joining OBBR, Dr. Carithers was a Christine Mirzayan Science and Technology Policy Graduate Fellow at the National Academies. She received her B.S. degree in Biology from Spelman College in Atlanta, Georgia and went on to receive her Ph.D. in Pathobiology and Molecular Medicine from Columbia University.
Building a Biobank: Nuts and Bolts
Liz Horn, Ph.D., Director, Genetic Alliance Registry and Biobank, Genetic Alliance
Biography: Liz Horn is the director of the Genetic Alliance Registry & BioBank, and has served on the BioBank advisory board since 2004. She earned her doctorate in Molecular Pharmacology and Cancer Therapeutics from SUNY at Buffalo, NY. She was a National Library of Medicine fellow in biomedical informatics and received her MBI from Oregon Health & Science University. She has worked in the nonprofit sector for the past nine years, developing and advancing research initiatives for patient and physician advocacy organizations, with a focus on registries and biobanks. She is trained in both quantitative and qualitative methods, and has conducted focus groups, consensus exercises, and various surveys, including a national survey panel. Liz has developed a wide variety of educational and training materials for medical professionals and consumers, breaking down complex medical and scientific concepts. She recently developed a suite of tools for individuals establishing or managing registries or biobanks. She is passionate about cultivating non-traditional research collaborations, exploring governance issues in biobanking, and developing citizen scientist-driven research initiatives.
NEALS ALSBankTM Virtual BioRepository
Alex Sherman, Director, Systems, Neurology, Massachusetts General Hospital
Biography: Alex Sherman has 29 years of experience in research, research infrastructure development, software development, software architecture, expert systems design, clinical trials systems design, data management and clinical research management. Mr. Sherman has worked with Massachusetts General Hospital (MGH) and the Neurological Clinical Research Institute for the past 10 years. He is responsible for successful design, development and deployment of software systems for numerous clinical trials and biomarker studies in neurological diseases and for the technological platform behind NEALS ALS Consortium (www.alsconsortium.org), a research network of 105 academic institutions around the world. He also served as CEO of PharmaContent, Inc., a software development company that designs and develops software systems for clinical research. Mr. Sherman's other relevant experiences include a position as a Board of Directors member for Clinical Data Corporation (NASD:CLDA), a biotechnology company, and as a Director of Strategic Development at CogniMed LLC, a company that developed expert systems for disease management. Mr. Sherman holds Master's of Science degree in Nuclear Engineering and graduated from a doctorate program in Nuclear Engineering. He is a frequent speaker at academic and industry conferences and has many publications on the topics of collaboration in clinical research, data and biospecimen sharing and technology utilization for these purposes.
About the Conference:
With an eye to the value of precious clinical biosamples, Cambridge Healthtech Institute’s fourth annual Leaders in Biobanking Congress addresses both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best tactics for effective use of biospecimens within today’s cutting edge research.